Aixtron posts Q2 sales above market expectations
(Reuters) -German chip systems manufacturer Aixtron reported a better than expected quarterly revenue on Thursday, citing increasing demand for datacom lasers particularly for AI centers.
The group's sales rose 4% to 137.4 million euros ($156.9 million) in the second quarter of 2025, at the upper end of its guided range of 120-140 million euros and above analysts' average estimate of 128.2 million euros in an LSEG poll.
Its quarterly earnings before interest and taxes (EBIT) amounted to 23.6 million euros, up from 12.9 million a year earlier, exceeding analysts' forecast of 22.6 million euros, according to LSEG data.
"Although a broader market recovery has yet to take shape, our strong execution keeps us firmly on track," CEO Felix Grawert said in a statement.
Felix added that the company sees continued momentum in the datacom laser market, even if silicon carbide (SiC) and gallium nitride (GaN) power electronics markets have not reached the turning point yet.
The company said it will continue to monitor the impact of U.S. tariff policies on the global economy and any resulting countermeasures.
U.S. President Donald Trump's sweeping tariffs and uncertainty over his trade policies have sent global markets into a tailspin and significantly dampened investors' economic optimism.
Aixtron confirmed its full-year outlook for 2025, expecting revenue between 530 million and 600 million euros, down from 633.2 million euros in 2024.
($1 = 0.8756 euros)
(Reporting by Ozan Ergenay in Gdansk, editing by Milla Nissi-Prussak and Matt Scuffham)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
a day ago
- The Star
‘Every day, we think about how to upgrade': China's factories see rise in robot adoption
GUANGZHOU (The Straits Times/ANN): When Sun Huihai first began working at a factory in the southern manufacturing belt of Guangdong some 13 years ago, his colleagues were all humans. Now, they are joined by more than 200 robots which can work around the clock, seven days a week, to help produce air-conditioners for home appliances giant Midea. Rows of bright orange robot arms whir at all hours of the day, fishing freshly pressed plastic parts out of hot metal moulds and onto a long conveyor belt. Driverless robots with blinking lights store these parts in a multi-storey warehouse, and later take them to be assembled into units that are sold in China and around the world. The number of robots put to work on the factory floor increases every year, said Mr Sun, 37, who heads the plant's engineering department. 'Every day, we think about how to upgrade and make manufacturing here more intelligent,' he told The Straits Times. Scenes like this have become more common across China, as the 'factory of the world' turns to robotics to sustain and turbocharge its manufacturing juggernaut. Over the past decade, the number of industrial robots on China's factory floors has increased more than six times to over 1.7 million, as companies grappled with rising wages and a shortage of workers willing to staff production lines. China now has the world's third-highest density of robots in its manufacturing industry, trailing South Korea and Singapore in first and second place respectively, according to the International Federation of Robotics' figures for 2023, the latest available. Their deployment is poised to increase further as China continues its transition from low-value, labour-intensive production to advanced manufacturing – a national priority. 'At any given time, China cannot do without the manufacturing industry,' said Chinese President Xi Jinping in 2023. 'The state will strongly support the development of high-end manufacturing,' he added. Policymakers in China, wary of the hollowing out of industries which can occur when countries get richer, have long pushed for greater automation to keep factories competitive. A decade ago, the government rolled out 'Made in China 2025', a plan to upgrade manufacturing and become a production hub for high-tech sectors such as robots. Rebates, subsidies and other incentives have been offered to encourage factories to automate. A rise in domestic production of industrial robots has also reduced prices, making the machines more affordable. Factories in China pumped out nearly 370,000 of such robots in the first half of 2025, up 35.6 per cent from the previous year, according to figures from the National Bureau of Statistics. At the Midea factory in Nansha, Guangzhou, where Mr Sun works, there are 204 robotic arms and 82 automated guided vehicles. They are supplied by Kuka, a German industrial robot giant which the Chinese company bought over. One section of the plant, where plastic parts for the air-conditioner are moulded and retrieved, is dubbed a 'dark (heideng)' area. It is so named because of the high degree of automation: In theory, it can run without humans or any lights on, but in practice, it is brightly lit here at the plant. Not every part of the factory is as automated, a costly endeavour. Humans are needed to staff assembly lines, maintain the machines, and check the quality of manufactured parts. The facility employs some 4,000 workers during peak season, Mr Sun says. Elsewhere, other manufacturers of electrical items, electronics and cars – the main users of industrial robots in China – have also ramped up the use of technology on their factory floors. 'Dark factories' have become a buzzword to describe the most advanced of China's production facilities. Such operations have reportedly been adopted by companies ranging from home appliance giants Xiaomi and Gree to automakers Changan and Zeekr. As robot adoption picks up pace, one question that arises is: What will happen to the more than 100 million workers whom China's manufacturing sector employs? The automation drive has at times been dubbed 'replace humans with robots (jiqi huanren)'. In 2021, Gree's chairman said that the company's 'dark factory' had slashed the need for workers at the plant from 10,000 to 1,000. In Mr Sun's telling, employment at Midea's air-conditioner factory has remained roughly unchanged from a decade ago. What has changed, he said, is productivity. The number of air-conditioners the factory produces has more than tripled from 2015, company figures show. Academics Nicole Wu and Sun Zhongwei, who interviewed and surveyed factory workers in southern China just prior to the Covid-19 pandemic, found that these individuals were not too concerned about robots just yet. 'Contrary to the more pessimistic assessments of automation, most manufacturing workers in Guangdong – who are buffered by steady increases in demand and a chronic labour shortage – appear to be unfazed by technological change at present,' they wrote in a paper published this year. As China's birth rate falls and the population grows more educated, it has become more difficult for factory bosses to fill jobs, said Professor Sun Zhongwei, who studies industrial relations and social security at the South China Normal University. He is not worried that the automation drive will go so far as to undermine the manufacturing jobs often seen as a means of stabilising employment, because market forces are at play. Automation is a rational process, and industrial robots are a sizeable investment, Prof Sun said. 'Companies will need to calculate whether the cost of the machinery justifies the wages saved.' Still, he added, the biggest losers as manufacturing goes high-tech are lower educated, older migrant workers who lack the skills to remain relevant. Many will have to return to their rural homes to do odd jobs, while others might find employment as service staff. Back at the Midea factory, Mr Wang Liangcai, 26, an engineer, believes that his job is safe from automation for now. 'Equipment still needs to be maintained, it can't do so itself,' he said. 'But if you think about the long run... we also don't know how things will be.' - The Straits Times/ANN
Sinar Daily
2 days ago
- Sinar Daily
Who makes laundry smell nice? Meet the professional 'noses'
HOLZMINDEN - In the laboratories of German fragrance and flavours giant Symrise, a citrus scent clings to the lab coats of trainees, "noses" who are learning the art of making things smell good. These busy heroes of the world of smells and aromas shape the connection millions of consumers have with everyday items. While at high-end perfume labels, olfactory artists create scents for luxury body sprays, Symrise's experts work on everyday products that might range from mint-flavoured toothpaste to barbeque chips. Smell, a powerful sense that can trigger emotions and memories, and aroma often decide which food or beverage, cleaning or personal hygiene product ends up in the shopping cart. At Symrise's headquarters in Holzminden, a quiet town south of Hanover, each day at the company's in-house perfumery school begins the same way: sniffing out scents from dozens of tiny bottles while blindfolded. "It's just like tuning a musical instrument before you play," said Alicia De Benito Cassado, a 32-year-old former professional pianist from Spain. Her career switch into scent development was a natural step: she made her own perfumes as a teenager to match the poetry and music that she wrote. "For me, not everything has to smell good," she said. "The horror of smell also helps us discover ourselves." But commercial clients demand something different, De Benito Cassado added. "In the end, we need to create scents that are strong, beautiful, powerful and affordable." - Professional sniffers - Being a "nose" is a full-time job and comes with a three-year training programme. The smell of a fabric softener can be composed of 80 compounds, far more than in a premium body perfume and the best noses can make out over 1,000 different odours while blindfolded. Junior perfumers (L-R) Attiya Setai, Shangyun Lyu and Alicia de Benito Cassado hold smell strips which are used to evaluate fragrances in a mixing room at the Symrise company, where perfume oil formulas are developed, in Holzminden, central Germany. Photo by Michael Matthey/AFP Shangyun Lyu, 31, came from China to study at the school and says that a professional sniffer can get by with knowing about 500 scents. Being able to break down odours into their chemical components is key. "As a kid, I just smelled jasmine or gardenia as flowers," he said. "Now, I recognise the chemicals: it's a blend of many elements." Students weigh ingredients down to the milligramme, mix, smell and start over, often by replicating existing smells to understand their structure and then innovate from there. "When developing perfume, it is very important that several people smell it," said 56-year-old master perfumer Marc vom Ende, head of the school. "We all perceive smell differently." - 'Nose has the final say' - Pleasant smells cannot come at any cost and the rules of the game change over time. Lilial, a chemical once prized for its floral and sweet Lily-of-the-Valley notes, has been banned in the European Union since 2022 over fears it can cause skin irritation and damage the reproductive system. Fragrances applied directly to the body have stricter regulations than detergents, said 27-year-old South African trainee Attiya Setai. "We're more restricted in raw materials and must replace banned ingredients with new compliant ones," she said. Tastes also vary across global markets, with Shangyun pointing to the example of Chinese shampoos that sell well with a young clientele there but would struggle in Europe. "Something old-fashioned in one country can be new elsewhere," he said. Cost also enters the equation. Symrise extracts aromatic compounds from wood resin, a by-product of the paper industry, in a move "that makes both economic and environmental sense", said vom Ende. It is hard to be a nose. About 500 perfumers work in the industry and 80 of them at Symrise, which has a workforce of 13,000. The company markets about 30,000 products to clients ranging from confectioners to pet food manufacturers and suncream makers. Symrise's competitors include DSM-Firmenich, headquartered in both Switzerland and the Netherlands, as well as Givaudan, another Swiss firm. Artificial intelligence increasingly plays a role, with computer programmes predicting which fragrances will hit the mark. Still, the machines cannot -- yet -- smell, even if they can understand speech and read text. "We're supported by AI," vom Ende said. "But the nose has the final say". - AFP
New Straits Times
2 days ago
- New Straits Times
Pfizer, BioNTech lose UK appeal to Moderna in Covid-19 vaccine patent fight
LONDON: US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms. It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech. "The judge made no error of law or principle" in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies. Pfizer quickly said it will appeal Friday's ruling to Britain's Supreme Court. "Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid," Pfizer said in a statement. "This decision has no immediate impact on Pfizer and BioNTech." Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed. Friday's decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland. Moderna said in a statement it was pleased with Friday's ruling and would "continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology." A UK court was told last year the firms had spent £19 million (US$25 million) fighting their legal battles. In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid pandemic. Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases. Traditional vaccines contain some form of the dead or inactivated target virus. Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines. In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines. It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide "appropriate compensation."--AFP
